GSK partners with CRISPR pioneer Doudna to search for new drugs

CRISPR pioneer Jennifer Doudna and CRISPR researcher Jonathan Weissman will work with GlaxoSmithKline in a new Bay Area drug discovery lab.
Jennifer Doudna, CRISPR developer and University of California, Berkeley, scientist. Source: Vincent Yu/AP

SAN FRANCISCO — The drug maker GlaxoSmithKline announced Thursday that it would team up with some of the nation’s most prominent CRISPR researchers to use the gene-editing technology in a search for new medicines, establishing a new lab in San Francisco and spending up to $67 million over five years.

Jennifer Doudna, the University of California, Berkeley, researcher who co-invented the CRISPR enzyme technology, will help lead the effort, along with Jonathan Weissman, a UC San Francisco researcher

You're reading a preview, sign up to read more.

More from STAT

STAT15 min read
How Purdue Planted Its ‘Anti-story’ And Delayed The Reckoning For Its Role In The Opioid Epidemic
Purdue Pharma funded think tanks tapped by the media for expert commentary and facilitated publication of sympathetic articles in leading outlets where its role wasn’t disclosed.
STAT3 min read
A New Bill Would Let More Doctors Prescribe Addiction Treatments Without Waiting For Insurers’ Permission
Fewer doctors would have to wait for permission to prescribe addiction treatment drugs under a new, bipartisan bill.
STAT11 min readWellness
A New Treatment Promises To Make Little People Taller. Is It An Insult To ‘Dwarf Pride’?
A new drug promises to make little people taller. To many, it’s a wondrous invention that could improve the lives of thousands. To others, it’s an affront.